Results 151 to 160 of about 389,587 (260)
Bone remodeling: a central mechanism in prostate cancer bone metastasis. [PDF]
Tang H, Chen J, Wu H, Lv Y, Wa Q, He S.
europepmc +1 more source
NeuroSuite provides a modular hardware‐software platform integrating Neuroweb and NeuroMaps to enable long‐term, in situ electrophysiological interrogation of air–liquid interface organoid slices while preserving tissue architecture. Its components can be used together or independently to capture real‐time activity, spatial network dynamics, and ...
Belquis Haider +14 more
wiley +1 more source
Microbial dysbiosis and inferred functional profiling reveals the potential role of <i>Methylobacterium</i> in prostate cancer. [PDF]
Al Shareef ZM +11 more
europepmc +1 more source
An immunomodulatory hydrogel (iGEL) forms spontaneously upon subcutaneous injection, acting as a tissue‐adhesive depot. It releases anti‐rejection and regenerative agents in response to inflammation, suppressing T‐cell activity, promoting vascular repair, and restoring allograft function without systemic immunosuppression.
Ning Wang +14 more
wiley +1 more source
Molecular determinants of AR-enhancer interaction and cistrome reprogramming in prostate cancer progression. [PDF]
Fernandes RC +3 more
europepmc +1 more source
Single‐cell longitudinal profiling reveals that androgen‐deprivation therapy induces a DPT+ fibroblast‐complement axis that suppresses macrophage inflammation and drives CD8+ T cell exhaustion in prostate cancer. Concurrently, resistant epithelial subpopulations persist and engage TSPAN1‐ and NRXN1‐mediated programs promoting CRPC and neuroendocrine ...
Yang Chen +19 more
wiley +1 more source
Elucidating the multitarget neuroprotective mechanisms of protocatechuic acid in neurological disorders (Review). [PDF]
Xue X, Lai Y, Song S, Wu L, Wang L.
europepmc +1 more source
Prostate cancer is immunologically ‘cold’, with scarce, dysfunctional type 1 conventional dendritic cells (cDC1s) that limit T cell priming. We introduce an aptamer‐targeted liposomedelivering FMS‐like tyrosine kinase 3 ligand (Flt3L) and chlorin e6 (Ce6). Ultrasound induces antigen release and cDC1s recruitment, creating an in situ cDC1 vaccine.
Jiayi Wang +8 more
wiley +1 more source
Long-term trends in the burden of prostate cancer in the United States from 1990 to 2021: A detailed analysis based on the Global Burden of Disease Study 2021. [PDF]
Guo G +6 more
europepmc +1 more source

